Back to BlackRock, Inc. BlackRock, Inc.

XERSXERS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in XERIS BIOPHARMA HOLDINGS INC

BlackRock, Inc. holds 14.5M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $115M as of 2026-Q2. The position was increased (+12.2% shares). XERS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$115M

Current Shares

14.5M

Total Value Change

+$78.4M

Total Shares Change

+3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
14.5M
+12.2%
$115M0.0%$7.92
34
2026-Q1
Increased
12.9M
+2.4%
$75.1M0.0%$5.94
30
2025-Q4
Increased
12.6M
+6.0%
$99.2M0.0%$7.31
32
2025-Q3
Increased
11.9M
+3.4%
$97.1M0.0%$8.08
31
2025-Q2
Increased
11.5M
+6.9%
$53.9M0.0%$4.70
31
2025-Q1
Decreased
10.8M
-0.3%
$59.3M0.0%$5.58
0
2024-Q4
New
10.8M
-
$36.7M0.0%$3.38
40

Other major holders of XERS: VANGUARD GROUP INC, D. E. Shaw & Co., Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used